517 related articles for article (PubMed ID: 24825142)
1. An insight into JAK-STAT signalling in dermatology.
Palanivel JA; Macbeth AE; Chetty NC; Levell NJ
Clin Exp Dermatol; 2014 Jun; 39(4):513-8. PubMed ID: 24825142
[TBL] [Abstract][Full Text] [Related]
2. JAK/STAT pathway modulation: Does it work in dermatology?
Gündüz Ö
Dermatol Ther; 2019 May; 32(3):e12903. PubMed ID: 30964573
[TBL] [Abstract][Full Text] [Related]
3. Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors.
Welsch K; Holstein J; Laurence A; Ghoreschi K
Eur J Immunol; 2017 Jul; 47(7):1096-1107. PubMed ID: 28555727
[TBL] [Abstract][Full Text] [Related]
4. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours.
Thomas SJ; Snowden JA; Zeidler MP; Danson SJ
Br J Cancer; 2015 Jul; 113(3):365-71. PubMed ID: 26151455
[TBL] [Abstract][Full Text] [Related]
5. JAK/STAT pathway in Drosophila immunity.
Myllymäki H; Rämet M
Scand J Immunol; 2014 Jun; 79(6):377-85. PubMed ID: 24673174
[TBL] [Abstract][Full Text] [Related]
6. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Coskun M; Salem M; Pedersen J; Nielsen OH
Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
[TBL] [Abstract][Full Text] [Related]
7. The Specific Roles of JAK/STAT Signaling Pathway in Sepsis.
Cai B; Cai JP; Luo YL; Chen C; Zhang S
Inflammation; 2015 Aug; 38(4):1599-608. PubMed ID: 25676437
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds.
Migita K; Izumi Y; Torigoshi T; Satomura K; Izumi M; Nishino Y; Jiuchi Y; Nakamura M; Kozuru H; Nonaka F; Eguchi K; Kawakami A; Motokawa S
Clin Exp Immunol; 2013 Dec; 174(3):356-63. PubMed ID: 23968543
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Janus Kinase Family in Autoimmune Skin Diseases.
Howell MD; Kuo FI; Smith PA
Front Immunol; 2019; 10():2342. PubMed ID: 31649667
[TBL] [Abstract][Full Text] [Related]
10. The JAK-STAT pathway: a therapeutic target in hematological malignancies.
Ferrajoli A; Faderl S; Ravandi F; Estrov Z
Curr Cancer Drug Targets; 2006 Dec; 6(8):671-9. PubMed ID: 17168672
[TBL] [Abstract][Full Text] [Related]
11. Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses.
Garcia-Melendo C; Cubiró X; Puig L
Actas Dermosifiliogr (Engl Ed); 2021; 112(7):586-600. PubMed ID: 34030992
[TBL] [Abstract][Full Text] [Related]
12. The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease.
Lashgari NA; Roudsari NM; Momtaz S; Sathyapalan T; Abdolghaffari AH; Sahebkar A
J Neuroimmunol; 2021 Dec; 361():577758. PubMed ID: 34739911
[TBL] [Abstract][Full Text] [Related]
13. JAK/STAT pathway mediates retinal ganglion cell survival after acute ocular hypertension but not under normal conditions.
Huang Y; Cen LP; Choy KW; van Rooijen N; Wang N; Pang CP; Cui Q
Exp Eye Res; 2007 Nov; 85(5):684-95. PubMed ID: 17869246
[TBL] [Abstract][Full Text] [Related]
14. Phosphospecific flow cytometry for pharmacodynamic drug monitoring: analysis of the JAK-STAT signaling pathway.
Vafadari R; Weimar W; Baan CC
Clin Chim Acta; 2012 Sep; 413(17-18):1398-405. PubMed ID: 22261016
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropy and redundancy of STAT proteins in early pregnancy.
Maj T; Chelmonska-Soyta A
Reprod Domest Anim; 2007 Aug; 42(4):343-53. PubMed ID: 17635769
[TBL] [Abstract][Full Text] [Related]
16. JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.
Banerjee S; Biehl A; Gadina M; Hasni S; Schwartz DM
Drugs; 2017 Apr; 77(5):521-546. PubMed ID: 28255960
[TBL] [Abstract][Full Text] [Related]
17. Janus kinase/signal transducer and activator of transcription pathways in spondyloarthritis.
Raychaudhuri SK; Raychaudhuri SP
Curr Opin Rheumatol; 2017 Jul; 29(4):311-316. PubMed ID: 28394822
[TBL] [Abstract][Full Text] [Related]
18. JAK inhibitor: Introduction.
Raychaudhuri SP; Raychaudhuri SK
Indian J Dermatol Venereol Leprol; 2023; 89(5):688-690. PubMed ID: 37609754
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and non-canonical aspects of JAK/STAT signalling.
Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
[TBL] [Abstract][Full Text] [Related]
20. Kurarinone regulates immune responses through regulation of the JAK/STAT and TCR-mediated signaling pathways.
Kim BH; Na KM; Oh I; Song IH; Lee YS; Shin J; Kim TY
Biochem Pharmacol; 2013 Apr; 85(8):1134-44. PubMed ID: 23333426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
